multiple sclerosis

Abbott a Step Closer to FACT
Yahoo/Zacks
Sat, 04/10/10 - 12:10 pm
Abbott Laboratories
Facet Biotech
daclizumab
multiple sclerosis
Biogen Idec
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Fri, 04/9/10 - 07:52 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen, Merck, Bayer MS Drugs Targeted by Test Predicting Which Ones Work
Bloomberg
Mon, 03/29/10 - 10:09 am
Biogen Idec
Merck
Bayer
MS
multiple sclerosis
New Insight Into Multiple-Sclerosis Treatment (beta -interferon)
Wall Street Journal
Sun, 03/28/10 - 01:11 pm
multiple sclerosis
beta-interferon
Acorda applies to extend Ampyra patent protection
Yahoo/AP
Mon, 03/22/10 - 09:54 am
Acorda Therapeutics
patents
AMPYRA
MS
multiple sclerosis
Stronger Label for Biogen's Tysabri
Yahoo/Zacks.com
Mon, 03/1/10 - 10:00 am
Biogen Idec
Elan
Tysabri
multiple sclerosis
Copaxone 15-Year Study In Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy And Safety
Medical News Today
Sun, 02/28/10 - 01:08 pm
Copaxone
multiple sclerosis
Teva Pharmaceuticals
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wed, 02/17/10 - 09:01 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:37 am
Teva Pharmaceuticals
Active Biotech
partnerships
MS
multiple sclerosis
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Wed, 01/27/10 - 10:57 am
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
Mon, 01/25/10 - 12:36 pm
MS
multiple sclerosis
Biogen Idec
FDA
AMPYRA
What the New MS Drug (AMPYRA) Does (and What It Doesn’t Do)
Wall Street Journal
Sat, 01/23/10 - 10:52 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Acorda Therapeutics Announces FDA Approval of AMPYRA (dalfampridine) to Improve Walking in People with Multiple Sclerosis - Demonstrated by Increases in Walking Speed
Yahoo/Business Wire
Sat, 01/23/10 - 10:50 am
Acorda Therapeutics
AMPYRA
multiple sclerosis
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thu, 01/21/10 - 09:01 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wed, 01/13/10 - 09:22 am
Biogen Idec
Tysabri
MS
multiple sclerosis
Biogen says 48,800 patients now on Tysabri
Marketwatch
Tue, 01/12/10 - 09:15 am
Biogen Idec
Tysabri
multiple sclerosis
Adeona Announces Additional $860,000 Grant for Oral Estriol Multiple Sclerosis Clinical Trial
Trading Markets
Sun, 01/10/10 - 11:37 am
Adeona
multiple sclerosis
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Fri, 12/4/09 - 08:38 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Fri, 11/13/09 - 08:55 am
Biogen Idec
social media
FDA
Tysabri
MS
multiple sclerosis
Avanir shares jump on new Zenvia data
Fierce Biotech
Wed, 11/11/09 - 08:24 am
Zenvia
Avanir
MS
multiple sclerosis

Pages